NeuroOne Medical Technologies Corporation (NMTC)

NMTC Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for NMTC.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for NMTC.

Recommendation Trends

Rating	May '23	Jun '23	Jul '23	Aug '23
Strong Buy	0	0	0	0
Buy	0	0	0	0
Hold	1	1	1	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	1	1	1	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ben Haynor Alliance Global Partners	Alliance Global Partners	Strong Buy Maintains $3.25 → $2.2	Strong Buy	Maintains	$3.25 → $2.2	+91.30%	Aug 15, 2023
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Mar 28, 2022
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+421.74%	Nov 15, 2021

More Analyst Ratings

Financial Forecast

Revenue This Year

13.57M

Increased by 292.88%

from 3.45M

Revenue Next Year

n/a

from 13.57M

EPS This Year

-0.29

from -0.46

EPS Next Year

n/a

from -0.29

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Sep 30, 2020	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025
Revenue	1.93M	242.96K	2.12M	3.41M	3.45M	13.57M
Revenue Growth	-	-87.39%	772.60%	60.73%	1.33%	292.88%
EPS	-2.52	-0.93	-0.63	-0.65	-0.46	-0.29
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025
High	14.0M
Avg	13.6M
Low	13.0M

Revenue Growth

Revenue Growth	2025
High	304.4%
Avg	292.9%
Low	277.5%

EPS Forecast

EPS	2025
High	-0.29
Avg	-0.29
Low	-0.27

EPS Growth

EPS Growth	2025
High	-
Avg	-
Low	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.